Expanding Use of CGM in Critical Care: Impact on Nurse Work Patterns and Patient Outcomes

Phase 1

Recruiting

• Conditions: Hyperglycemia

• Registration Number: NCT05571397
• Lead Sponsor: Ohio State University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-9-15
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Inclusion Criteria:<br><br> - adults >18 years old,<br><br> - admitted to Ohio State University Wexner Medical Center MICU and<br><br> - have hyperglycemia (glucose >250mg/dl) or are currently on IV insulin.<br><br>Exclusion Criteria:<br><br> - Current COVID-19 infection,<br><br> - Refractory shock (Levophed dose >0.5 mcg/kg/min or equivalent)<br><br> - Actively being treated for diabetic ketoacidosis (DKA)<br><br> - Actively being treated for hyperosmolar non-ketoacidosis (HONK)<br><br> - Pitting edema, anasarca, blue or purple discoloration to left upper extremity<br><br> - Treated with high dose acetaminophen (>1 gram Q6 hours)<br><br> - Treated with hydroxyurea<br><br> - Are pregnant, patients<br><br> - Using home insulin pump therapy during hospitalization, or<br><br> - Reside in a corrections institution.

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Time in Range

Secondary Outcome Measures

Name	Time	Method
Time in hypoglycemia